When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AZNCF - Amarin's Multiple Positives And Other News: The Good Bad And Ugly Of Biopharma
AstraZeneca Plc
Amarin Corporation PLC (AMRN) is currently on a roll as the company is gearing up for the expanded market launch of its potential blockbuster drug Vascepa, which is now the only drug approved in the United States for lowering the risk of cardiovascular events in conjunction with statin therapy. It is estimated that the drug may touch the peak sales volume of $3-4 billion a year. However, after certain developments in the market, some analysts are thinking that the drug may be able to garner even higher revenue.